Hormone replacement therapy and hypercoagulability. Results from the Prospective Danish Climacteric Study
نویسندگان
چکیده
Population One hundred and forty-nine postmenopausal women without previous venous thromboembolic disease. Methods Prothrombin fragment 1þ2 (F1þ2), fibrin degradation products, antithrombin, protein C, total protein S and activated protein C-normalised ratio were measured at baseline and after 6 and 12 months of HRT in six groups of healthy postmenopausal women: (A) no HRT (reference group), (B) continuous oestradiol valerate (E2V) plus cyproterone acetate, (C) cyclic E2V plus cyproterone acetate, (D) continuous combined oestrogen (E2) plus norethindrone acetate, (E) E2 combined with local delivery of levonorgestrel and (F) E2V plus medroxyprogesterone.
منابع مشابه
Comparison of Piascledine (Avocado and Soybean Oil) and Hormone Replacement Therapy in Menopausal-Induced Hot Flashing
Different symptoms in Climacteric period, includes hot flash. Hormone replacement therapy (HRT) is common therapy for relief of menopausal symptoms but has possible contraindications and side effects. Recently Piascledine (combination of Avocado oil with Soybean oil) showed effects in reducing hot flash severity. Present study designed to compare the effects of HRT with Piascledine in treatment...
متن کاملComparison of Piascledine (Avocado and Soybean Oil) and Hormone Replacement Therapy in Menopausal-Induced Hot Flashing
Different symptoms in Climacteric period, includes hot flash. Hormone replacement therapy (HRT) is common therapy for relief of menopausal symptoms but has possible contraindications and side effects. Recently Piascledine (combination of Avocado oil with Soybean oil) showed effects in reducing hot flash severity. Present study designed to compare the effects of HRT with Piascledine in treatment...
متن کاملCOHORT PROFILE Cohort Profile: The Danish nurse cohort
From the 1970s to the mid-1990s, 20–30% of Danish women between 55 and 65 years of age used hormone replacement therapy (HRT). It was primarily used to alleviate climacteric symptoms, but from 1980s the therapy was also used for prevention of osteoporosis and from the 1990s for prevention of cardiovascular diseases. The literature based on observational studies, primarily US studies, suggested ...
متن کاملNanostructured transdermal hormone replacement therapy for relieving menopausal symptoms: a confocal Raman spectroscopy study
OBJECTIVE To determine the safety and efficacy of a transdermal nanostructured formulation of progesterone (10%) combined with estriol (0.1%) + estradiol (0.25%) for relieving postmenopausal symptoms. METHODS A total of 66 postmenopausal Brazilian women with climacteric symptoms of natural menopause received transdermal nanostructured formulations of progesterone and estrogens in the forearm ...
متن کاملEconomic impact of tibolone compared with continuous-combined hormone replacement therapy in the management of climacteric symptoms in postmenopausal women
Health technology The study assessed a 3-year treatment course of tibolone, a synthetic steroid that has estrogenic, progestogenic and androgenic properties, in the management of postmenopausal women with climacteric symptoms. Tibolone was taken daily at a dose of 2.5 mg and was taken orally. The treatment was compared with continuous combined hormone replacement therapy, which comprised conjug...
متن کامل